Literature DB >> 14726378

SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease.

Reza Sharifi1, Joanna C Sinclair, Kimberly C Gilmour, Peter D Arkwright, Christine Kinnon, Adrian J Thrasher, H Bobby Gaspar.   

Abstract

Cytotoxic T cells (CTLs) and natural killer cells play a major role in the immune response to Epstein-Barr virus (EBV) infection. In X-linked lymphoproliferative (XLP) disease, a severe immunodeficiency, immunodysregulatory phenomena are observed following EBV infection, suggesting that defects exist in these effector populations. The gene defective in XLP is SAP (signaling lymphocytic activation molecule [SLAM]-associated protein), an adaptor protein that mediates signals through SLAM and other immunoglobulin superfamily receptors including 2B4. We generated EBV-specific T-cell lines from controls and XLP patients and examined CTL function in response to different stimuli. We show that XLP patients can generate EBV-T-cell lines that are phenotypically similar to those from controls. XLP patient EBV-T-cell lines showed a significant decrease in interferon-gamma (IFN-gamma) production in response to 2B4 and autologous EBV-transformed lymphoblastoid cell line (LCL) stimulation but not in response to SLAM. Furthermore, XLP EBV-T-cell lines demonstrated markedly decreased cytotoxic activity against autologous LCLs. By retroviral gene transfer of the SAP gene into XLP EBV-T-cell lines, we show reconstitution of IFN-gamma production and of cytotoxic activity confirming SAP-dependent defects. These studies demonstrate that in XLP the lack of SAP affects specific signaling pathways resulting in severe disruption of CTL function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14726378     DOI: 10.1182/blood-2003-09-3359

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  33 in total

1.  X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.

Authors:  Claire Booth; Kimberly C Gilmour; Paul Veys; Andrew R Gennery; Mary A Slatter; Helen Chapel; Paul T Heath; Colin G Steward; Owen Smith; Anna O'Meara; Hilary Kerrigan; Nizar Mahlaoui; Marina Cavazzana-Calvo; Alain Fischer; Despina Moshous; Stephane Blanche; Jana Pachlopnik Schmid; Jana Pachlopnick-Schmid; Sylvain Latour; Genevieve de Saint-Basile; Michael Albert; Gundula Notheis; Nikolaus Rieber; Brigitte Strahm; Henrike Ritterbusch; Arjan Lankester; Nico G Hartwig; Isabelle Meyts; Alessandro Plebani; Annarosa Soresina; Andrea Finocchi; Claudio Pignata; Emilia Cirillo; Sonia Bonanomi; Christina Peters; Krzysztof Kalwak; Srdjan Pasic; Petr Sedlacek; Janez Jazbec; Hirokazu Kanegane; Kim E Nichols; I Celine Hanson; Neena Kapoor; Elie Haddad; Morton Cowan; Sharon Choo; Joanne Smart; Peter D Arkwright; Hubert B Gaspar
Journal:  Blood       Date:  2010-10-06       Impact factor: 22.113

2.  Prevalence of SAP gene defects in male patients diagnosed with common variable immunodeficiency.

Authors:  D Eastwood; K C Gilmour; K Nistala; C Meaney; H Chapel; Z Sherrell; A D Webster; E G Davies; A Jones; H B Gaspar
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

3.  Positive and negative signaling through SLAM receptors regulate synapse organization and thresholds of cytolysis.

Authors:  Fang Zhao; Jennifer L Cannons; Mala Dutta; Gillian M Griffiths; Pamela L Schwartzberg
Journal:  Immunity       Date:  2012-06-07       Impact factor: 31.745

Review 4.  XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus.

Authors:  Feng-Yen Li; Benjamin Chaigne-Delalande; Helen Su; Gulbu Uzel; Helen Matthews; Michael J Lenardo
Journal:  Blood       Date:  2014-02-18       Impact factor: 22.113

5.  2B4-SAP signaling is required for the priming of naive CD8+ T cells by antigen-expressing B cells and B lymphoma cells.

Authors:  Yu-Hsuan Huang; Kevin Tsai; Sara Y Tan; Sohyeong Kang; Mandy L Ford; Kenneth W Harder; John J Priatel
Journal:  Oncoimmunology       Date:  2016-12-27       Impact factor: 8.110

6.  Inducible T Cell Kinase Regulates the Acquisition of Cytolytic Capacity and Degranulation in CD8+ CTLs.

Authors:  Senta M Kapnick; Jane C Stinchcombe; Gillian M Griffiths; Pamela L Schwartzberg
Journal:  J Immunol       Date:  2017-02-17       Impact factor: 5.422

Review 7.  X-linked lymphoproliferative disease (XLP): a model of impaired anti-viral, anti-tumor and humoral immune responses.

Authors:  Hamid Bassiri; W C Janice Yeo; Jennifer Rothman; Gary A Koretzky; Kim E Nichols
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

8.  High expression of CD244 and SAP regulated CD8 T cell responses of patients with HTLV-I associated neurologic disease.

Authors:  Yoshimi Enose-Akahata; Eiji Matsuura; Unsong Oh; Steven Jacobson
Journal:  PLoS Pathog       Date:  2009-12-04       Impact factor: 6.823

9.  Intronic SH2D1A mutation with impaired SAP expression and agammaglobulinemia.

Authors:  Mike Recher; Ari J Fried; Michel J Massaad; Hye Young Kim; Michela Rizzini; Francesco Frugoni; Jolan E Walter; Divij Mathew; Hermann Eibel; Christoph Hess; Silvia Giliani; Dale T Umetsu; Luigi D Notarangelo; Raif S Geha
Journal:  Clin Immunol       Date:  2012-12-07       Impact factor: 3.969

10.  The proapoptotic function of SAP provides a clue to the clinical picture of X-linked lymphoproliferative disease.

Authors:  Noémi Nagy; Liudmila Matskova; Loránd L Kis; Ulf Hellman; George Klein; Eva Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.